Accordingly, activated AMPK has been known to reverse insulin resistance, hyperglyceridemia, and body weight gain (8), which are now considered as a therapeutic target of obesity. The gene discussed is PRKAA1; the disease is obesity due to melanocortin 4 receptor deficiency.